Your browser doesn't support javascript.
loading
Skin tumours induced by narrowband UVB have higher frequency of p53 mutations than tumours induced by broadband UVB independent of Ogg1 genotype.
Yogianti, Flandiana; Kunisada, Makoto; Ono, Ryusuke; Sakumi, Kunihiko; Nakabeppu, Yusaku; Nishigori, Chikako.
Afiliación
  • Yogianti F; Division of Dermatology, Department of Internal Related, Graduate School of Medicine, Kobe University, Kobe, Japan.
Mutagenesis ; 27(6): 637-43, 2012 Nov.
Article en En | MEDLINE | ID: mdl-22844076
ABSTRACT
Different wavelengths of ultraviolet (UV) light have different promoting effects on skin carcinogenesis. Narrowband UVB (NB-UVB) has a single-peak wavelength of 311 nm and is widely used for treating skin diseases. Our previous work showed that, in comparison with conventional broadband UVB (BB-UVB), long-term exposure to NB-UVB induces higher frequency of skin cancer in mice, and it suggested that this is mediated through the formation of cyclobutane pyrimidine dimers (CPDs). To explore whether the frequency of p53 mutations in skin tumours correlates with CPD-induced mutations, we compared the frequency and types of p53 mutations between NB-UVB-induced and BB-UVB-induced malignant skin tumours produced in wild-type and Ogg1 knockout mice, which are deficient in repair of oxidative 8-oxoguanine (8-oxoG), a DNA damage mediated by reactive oxygen species (ROS). The frequency of p53 mutation was significantly higher in NB-UVB-induced than in BB-UVB-induced tumours in both wild-type and Ogg1 knockout mice. Most of the p53 mutations found were GC → AT transitions at dipyrimidine sites in both the NB-UVB- and BB-UVB-exposed groups. However, GC → TA mutations caused by 8-oxoG did not increase in Ogg1 knockout mice exposed to either NB-UVB or BB-UVB. Our results strongly suggest that NB-UVB induces highly malignant tumours caused by p53 dipyrimidine mutations through the formation of CPDs.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piel / Neoplasias Cutáneas / Proteína p53 Supresora de Tumor / ADN Glicosilasas / Genotipo / Mutación Límite: Animals Idioma: En Revista: Mutagenesis Asunto de la revista: GENETICA MEDICA / SAUDE AMBIENTAL Año: 2012 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piel / Neoplasias Cutáneas / Proteína p53 Supresora de Tumor / ADN Glicosilasas / Genotipo / Mutación Límite: Animals Idioma: En Revista: Mutagenesis Asunto de la revista: GENETICA MEDICA / SAUDE AMBIENTAL Año: 2012 Tipo del documento: Article País de afiliación: Japón